Amgen Inc SEC filings AMGN

Amgen Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 22, 2018. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Amgen Inc SEC filings
Form Description Filed Period
3 Initial insider ownership Oct 27, 2026 Oct 26, 2026
3 Initial insider ownership Sep 4, 2026 Sep 1, 2026
4 Insider transaction Aug 13, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 13, 2026 —
4 Insider transaction Aug 12, 2026 Aug 7, 2026
144 Notice of proposed sale Aug 11, 2026 —
4 Insider transaction Aug 10, 2026 Aug 7, 2026
4 Insider transaction Aug 10, 2026 Aug 7, 2026
4 Insider transaction Aug 10, 2026 Aug 7, 2026
4 Insider transaction Aug 7, 2026 Aug 6, 2026
4 Insider transaction Aug 7, 2026 Aug 6, 2026
144 Notice of proposed sale Aug 6, 2026 —
144/A Filing Aug 6, 2026 —
144 Notice of proposed sale Aug 6, 2026 —
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
SCHEDULE 13G Ownership over 5% (passive) May 14, 2026 —
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
144 Notice of proposed sale May 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
144 Notice of proposed sale Feb 27, 2026 —
4 Insider transaction Feb 20, 2026 Feb 19, 2026
144 Notice of proposed sale Feb 19, 2026 —
4 Insider transaction Feb 10, 2026 Feb 9, 2026
4 Insider transaction Nov 21, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 20, 2025 —
4 Insider transaction Nov 13, 2025 Nov 12, 2025
4 Insider transaction Nov 13, 2025 Nov 12, 2025
4 Insider transaction Nov 12, 2025 Nov 11, 2025
4 Insider transaction Nov 12, 2025 Nov 7, 2025
4 Insider transaction Nov 12, 2025 Nov 7, 2025
4 Insider transaction Nov 12, 2025 Nov 7, 2025
144 Notice of proposed sale Nov 12, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 8, 2025 —
4 Insider transaction Aug 22, 2025 Aug 20, 2025
144 Notice of proposed sale Aug 20, 2025 —
4 Insider transaction Aug 12, 2025 Aug 8, 2025
4 Insider transaction Aug 12, 2025 Aug 8, 2025
4 Insider transaction Aug 12, 2025 Aug 8, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
144 Notice of proposed sale Jun 5, 2025 —
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 28, 2025 May 23, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
144 Notice of proposed sale May 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
144 Notice of proposed sale Feb 21, 2025 —
4 Insider transaction Feb 20, 2025 Feb 18, 2025
144 Notice of proposed sale Feb 19, 2025 —
144 Notice of proposed sale Feb 19, 2025 —
144 Notice of proposed sale Feb 19, 2025 —
144 Notice of proposed sale Feb 18, 2025 —
4 Insider transaction Feb 13, 2025 Feb 11, 2025
144 Notice of proposed sale Feb 11, 2025 —
4 Insider transaction Feb 10, 2025 Feb 7, 2025
144 Notice of proposed sale Feb 7, 2025 —
4 Insider transaction Feb 6, 2025 Feb 5, 2025
144 Notice of proposed sale Feb 5, 2025 —
4 Insider transaction Dec 6, 2024 Dec 5, 2024
4 Insider transaction Dec 3, 2024 Dec 2, 2024
4 Insider transaction Nov 6, 2024 Nov 5, 2024
4 Insider transaction Nov 6, 2024 Nov 5, 2024
4 Insider transaction Nov 6, 2024 Nov 4, 2024
4 Insider transaction Nov 6, 2024 Nov 4, 2024
4 Insider transaction Nov 6, 2024 Nov 4, 2024
SC 13G/A Amended ownership over 5% (passive) Aug 23, 2024 —
4 Insider transaction Aug 13, 2024 Aug 9, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
AMGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Thousand Oaks, CA
SEC filer status
Large accelerated filer
SEC CIK
318154

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.